MYOV Crosses Above Average Analyst Target
October 04, 2022 at 07:00 AM EDT
In recent trading, shares of Myovant Sciences Ltd (MYOV) have crossed above the average analyst 12-month target price of $22.80, changing hands for $24.44/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..